| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A personalised taper-to-target strategy with adalimumab in Crohn's disease
|
Dreesen, Erwin
|
|
|
8 |
4 |
p. 293-294
|
article
|
| 2 |
Breaking the unspoken rules of UK training in gastroenterology and hepatology
|
Raju, Suneil A
|
|
|
8 |
4 |
p. 297-299
|
article
|
| 3 |
Bringing organ preservation closer for selected patients with rectal cancer
|
Rutten, Harm J T
|
|
|
8 |
4 |
p. 294-295
|
article
|
| 4 |
Cause for concern: the rising incidence of early-onset pancreatic cancer
|
The Lancet Gastroenterology & Hepatology,
|
|
|
8 |
4 |
p. 287
|
article
|
| 5 |
Closing the gender gap in gastroenterology leadership
|
Bowker-Howell, Freya J
|
|
|
8 |
4 |
p. 302
|
article
|
| 6 |
Combination biologic therapy for ulcerative colitis
|
Vermeire, Severine
|
|
|
8 |
4 |
p. 288-290
|
article
|
| 7 |
Correction to Lancet Gastroenterol Hepatol 2023; 8: 343–55
|
|
|
|
8 |
4 |
p. e4
|
article
|
| 8 |
Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial
|
Borup, Christian
|
|
|
8 |
4 |
p. 321-331
|
article
|
| 9 |
Global reporting of progress towards elimination of hepatitis B and hepatitis C
|
Cui, Fuqiang
|
|
|
8 |
4 |
p. 332-342
|
article
|
| 10 |
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
|
Feagan, Brian G
|
|
|
8 |
4 |
p. 307-320
|
article
|
| 11 |
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial
|
van Linschoten, Reinier C A
|
|
|
8 |
4 |
p. 343-355
|
article
|
| 12 |
Jo vs Cancer
|
Ashley-Norman, Phoebe
|
|
|
8 |
4 |
p. 306
|
article
|
| 13 |
Lessons from a trial of colesevelam for bile acid diarrhoea
|
Walters, Julian R F
|
|
|
8 |
4 |
p. 290-291
|
article
|
| 14 |
Management of inflammatory bowel diseases in older adults
|
Singh, Siddharth
|
|
|
8 |
4 |
p. 368-382
|
article
|
| 15 |
Mayflies: a drama limited by time
|
Moody, Joe
|
|
|
8 |
4 |
p. 305
|
article
|
| 16 |
Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial
|
Gerard, Jean-Pierre
|
|
|
8 |
4 |
p. 356-367
|
article
|
| 17 |
Overcoming disparities for sexual and gender minority patients and providers in gastroenterology and hepatology: introduction to Rainbows in Gastro
|
Duong, Nikki
|
|
|
8 |
4 |
p. 299-301
|
article
|
| 18 |
Progress towards elimination of hepatitis C in the UK
|
Burki, Talha
|
|
|
8 |
4 |
p. 303
|
article
|
| 19 |
Research in Brief
|
Baker, Holly
|
|
|
8 |
4 |
p. 304
|
article
|
| 20 |
Strategic information to guide elimination of viral hepatitis
|
Hiebert, Lindsey
|
|
|
8 |
4 |
p. 291-292
|
article
|
| 21 |
Understanding and managing patients with overlapping disorders of gut–brain interaction
|
Balsiger, Lukas Michaja
|
|
|
8 |
4 |
p. 383-390
|
article
|
| 22 |
Universal hepatitis C virus screening and treatment as part of prenatal care
|
Marshall, Alison D
|
|
|
8 |
4 |
p. 295-297
|
article
|
Journal description